Univariate analysis revealed that the overall survival of AML patients significantly correlated with age, FAB classifications, cytogenetics risk, IDH1, and SMPDL3B expression level (all p < 0.05). The gene discussed is SMPDL3B; the disease is acute myeloid leukemia.